{16 (treprostinil 0.032 MG Inhalation Powder [Tyvaso]) / 16 (treprostinil 0.048 MG Inhalation Powder [Tyvaso]) } Pack [Tyvaso 32-48 MCG Institutional Pack]
RxNorm concept 2602772, branded pack (bpck). Prescribable name: Tyvaso DPI 32-48 MCG Institutional Pack.
- RxCUI
- 2602772
- Term type
- Branded pack (BPCK)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2602772 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- treprostinil 0.032 MG Inhalation Powder [Tyvaso] (SBD, contains)
- treprostinil 0.048 MG Inhalation Powder [Tyvaso] (SBD, contains)
- Pack (DF, has dose form)
- {16 (treprostinil 0.032 MG Inhalation Powder) / 16 (treprostinil 0.048 MG Inhalation Powder) } Pack (GPCK, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2602772 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2602772 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2602772. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.